ZEISS CT LUCIA 602
Reliable monofocal hydrophobic, 3-piece-IOL performance
The CT LUCIA® 602 is an aspheric 3-piece IOL from ZEISS. Featuring highly stable PVDF haptics designed to ensure IOL stability in the capsular bag1,2. CT LUCIA 3-piece IOLs from ZEISS are glistening-free3 and have a 360° square edge design for a low PCO rate4.
ZEISS CT LUCIA 602
Monofocal, aspheric IOL
- Monofocal, aspheric
- PVDF haptics designed for good capsular bag stability1,2 and to eliminate capsular bag stretching.
- 360° square-edge design to reduce PCO.
- Featuring the patented ZO Asphericity Concept (ZO: ZEISS Optic) designed to compensate for a range of aberrations, providing better image quality in real-life conditions.
High corrected visual acuity5
The high stability of the lens in the capsular bag supports good visual outcomes after surgery.
Good refractive results5
IOL stability in the capsular bag, in conjunction with a low amount of post-surgery complications, facilitates good refractive results.
Low inflammatory reaction5
The safety of the lens after implantation proved to be reassuring with low rates of post-surgery events. Inflammatory reaction were minimal and mostly related to the procedure itself and not to the IOL.
Handling instruction video
Downloads
Specifications
ZEISS CT LUCIA 602
Get in touch with us!
Receive more information about the product and availability in your country!
-
1
EC-3 Pivotal Clinical Study (FDA IDE) (354 eyes): tilt 0 (0%), decentration 1 (0.3%) at 12M FU
-
2
EC-3 Pivotal Clinical Study (FDA IDE) (101 eyes): tilt 0 (0%), decentration 0 (0%) at 3Y+ FU
-
3
EC-3 Pivotal Clinical Study (FDA IDE): no glistenings (0%) at 12M (354 eyes)+ over 3.7Y FU (101 eyes).
-
4
EC-3 Pivotal Clinical Study (FDA IDE) (354 eyes): 22,3% minimal PCO, 4,8% moderate PCO, 0,6% dense PCO up to 12M FU.
-
5
EC-3 Pivotal Clinical Study (FDA IDE study): n=324, 12 month
-
6
For optimized A Constants and ACD Constants refer to IOLCon: https://iolcon.org/lensesTable.php. Last retrieved 2019-02-28